Tasly Pharmaceutical Group Co., Ltd

This early-phase study tests a new oral drug, TSL2109, in people with advanced solid tumors, especially prostate and breast cancers that have stopped responding to standard treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors o…

This early-phase trial tests a new treatment called P134 cells for people with recurrent glioblastoma, an aggressive brain cancer that has come back. P134 cells are immune cells engineered to target two proteins (CD44 and CD133) found on tumor cells. The study will enroll 26 adul…

This study tests a single injection of stem cells (B2065) given within 36 hours of a stroke. The goal is to see if it is safe and might help patients recover better. Fifty-four adults with moderate to severe stroke will receive either the stem cells or a placebo, and be followed …

This study tests whether injecting stem cells from umbilical cords into the heart during bypass surgery can help repair heart muscle and improve function in people with chronic heart failure. About 51 adults with weak hearts (ejection fraction 40% or less) will take part. The goa…

This Phase 3 trial tests whether Lianxiaxiaopi Granules, a traditional Chinese herbal medicine, can relieve symptoms of postprandial distress syndrome (stomach discomfort, fullness, or early fullness after meals). 342 adults aged 18-65 will take the granules or a placebo three ti…